Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: The European experience

Epilepsia

Volumn 38, Issue SUPPL. 1, 1997, Pages

  Ben Menachem, Elinor ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticonvulsants; Clinical trials; Drug interactions; Drug toxicity; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; PLACEBO; TOPIRAMATE;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; EUROPE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030997223     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb04514.x     Document Type: Conference Paper

References (12)

1. Maryanoff BE, Margul BL. Topiramate. Drugs Future 1989;14:342-4.
2. Shank RP, Gardocki JF, Vaught JL, et al. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia 1994;35:450-60.
3. Perucca E. Pharmacokinetic profile of topiramate in comparison to other new antiepileptic drugs. Epilepsia 1996;37(suppl 2):S8-13.
4. Bourgeois BFD. Drug interaction profile of topiramate. Epilepsia 1996;37(suppl 2):S14-7.
5. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400 and 600 mg daily dosages. Neurology 1996;46:1684-90.
6. Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600, 800 and 1,000 mg daily dosages. Neurology 1996;46:1678-83.
7. Sharieff M, Viteri C, Ben-Menachem E, et al. Double-blind, placebo-controlled study of topiramate in patients with partial epilepsy. Epilepsy Res 1996;25:217-24.
8. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled study of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-8.
9. Ben-Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996;37:539-43.
10. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284-91.
11. The U.S. Gabapentin Study Group No. 5. Gabapentin as add-on therapy in refractory partial epilepsy; a double-blind, placebo-controlled, parallel group study. Neurology 1993;43:2292-8.
12. French JA, Mosier M, Walker S, et al. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Neurology 1996;46:54-61.